Treatment of refractory trigeminal neuralgia with intravenous phenytoin

American Journal of Health-System Pharmacy

Volumn 68, Issue 21, 2011, Pages 2059-2061

  Tate, Rebekah ^a   Rubin, Lisa M ^b   Krajewski, Kristin C ^b  

^a Coram Specialty Infusion Services ^*  (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

Analgesics and antipyretics; Anticonvulsants; Blood levels; Carbamazepine; Dosage schedule; Ergocalciferol; Geriatrics; Phenytoin sodium; Saw palmetto; Toxicity; Trigeminal neuralgia; Warfarin sodium

Indexed keywords

ANTIBIOTIC AGENT; BACLOFEN; CARBAMAZEPINE; ERGOCALCIFEROL; GABAPENTIN; HYDROCODONE BITARTRATE; HYDROMORPHONE; PARACETAMOL; PHENYTOIN; SODIUM CHLORIDE; TERAZOSIN; TRAMADOL; WARFARIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; ATAXIA; BEDTIME DOSAGE; CASE REPORT; CHRONIC DISEASE; CONTINUOUS INFUSION; DEHYDRATION; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; HEART ATRIUM FIBRILLATION; HUMAN; JAW PAIN; MALE; PAIN; PAIN ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SABAL; TRIGEMINUS NEURALGIA;

EID: 80455140464     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100636     Document Type: Article

References (12)

1. Kugelberg E, Lindblom U. The mechanism of the pain in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1959; 22:36-43.
2. Prasad S, Galetta S. Trigeminal neuralgia: historical notes and current concepts. Neurologist. 2009; 15:87-94.
3. Bauman JL, DiDomenico RJ, Galanter WL. Mechanisms, manifestations, and management of digoxin toxicity in the modern era. Am J Cardiovasc Drugs. 2006; 6:77-86.
4. Schulman EA, Silberstein SD. Symptomatic and prophylactic treatment of migraine and tension-type headache. Neurology. 1992; 42(suppl 2):16-21.
5. Wright JM. Review of the symptomatic treatment of diabetic neuropathy. Pharmacotherapy. 1994; 14:689-97. (Pubitemid 24371223)
6. Cruccu G, Gronseth G, Alksne J et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008; 15:1013-28.
7. Gronseth G, Cruccu G, Alksne J et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review). Neurology. 2008; 71:1183-90.
8. Obermann M, Katsarava Z. Update on trigeminal neuralgia. Expert Rev Neurother. 2009; 9:323-9.
9. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002; 18:22-7. (Pubitemid 34118962)
10. McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg. 1999; 89:985-8. (Pubitemid 29458478)
11. Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manage. 2001; 21:506-10.
12. Cranford RE. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology. 1978; 28:874-80. (Pubitemid 8390039)